GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vilacto Bio Inc (GREY:VIBI) » Definitions » Total Equity

Vilacto Bio (Vilacto Bio) Total Equity : $-2.51 Mil (As of Jun. 2019)


View and export this data going back to 2013. Start your Free Trial

What is Vilacto Bio Total Equity?

Vilacto Bio's total equity for the quarter that ended in Jun. 2019 was $-2.51 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Vilacto Bio Total Equity Historical Data

The historical data trend for Vilacto Bio's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vilacto Bio Total Equity Chart

Vilacto Bio Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19
Total Equity
Get a 7-Day Free Trial -0.01 -0.03 -0.04 -0.94 -3.42

Vilacto Bio Quarterly Data
Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.88 -3.21 -4.20 -3.42 -2.51

Vilacto Bio Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Vilacto Bio's Total Equity for the fiscal year that ended in Mar. 2019 is calculated as

Total Equity=Total Assets(Q: Mar. 2019 )-Total Liabilities(Q: Mar. 2019 )
=0.538-3.96
=-3.42

Vilacto Bio's Total Equity for the quarter that ended in Jun. 2019 is calculated as

Total Equity=Total Assets(Q: Jun. 2019 )-Total Liabilities(Q: Jun. 2019 )
=0.402-2.914
=-2.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vilacto Bio Total Equity Related Terms

Thank you for viewing the detailed overview of Vilacto Bio's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Vilacto Bio (Vilacto Bio) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vilacto Bio Inc (GREY:VIBI) » Definitions » Total Equity
Comparable Companies
CAW SUMR HKSE:01259 XKRX:266870 XBUL:4L4 DHA:GOLDENSON XKLS:5022 CAI:COSG XKLS:7149 LSE:CRL MIL:FED IST:DENCM WAR:DEL TPE:1732 XBUL:6AR XKLS:0049 ASX:ZNO BOM:506522 ZAG:SAPN WAR:HRP
Traded in Other Exchanges
N/A
Address
Fabriksvej 48, Suite 2607, The Seagram Building, Naestved, DNK, 4700
Website
https://www.vilacto.com
Vilacto Bio Inc is a biotech company. It operates a fully patented Lactoactive molecule for treating conditions such as inflammatory diseases, diabetics, psoriasis, and skin issues in different levels. The company is also intended to develop Lactoactive molecule for increasing the quality of its retail and medical skin cream product as well as developing products for medical applications. Its product portfolio includes lotions, skin care creams and gels, lip balms, foot creams and oils, and others.